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ABSTRAC 
Purpose: Setting a proper margin is crucial for not only delivering the required radiation dose to 
a target volume, but also reducing the unnecessary radiation to the adjacent organs at risk. This 15 
study investigated the independent one-dimensional symmetric and asymmetric margins between 
the clinical target volume (CTV) and the planning target volume (PTV) for linac-based single-
fraction frameless stereotactic radiosurgery (SRS).  
Methods and Materials: We assumed a Dirac delta function for the systematic error of a 
specific machine and a Gaussian function for the residual setup errors. Margin formulas were 20 
then derived in details to arrive at a suitable CTV-to-PTV margin for single-fraction frameless 
SRS. Such a margin ensured that the CTV would receive the prescribed dose in 95% of the 
patients. To validate our margin formalism, we retrospectively analyzed nine patients who were 
previously treated with non-coplanar conformal beams. Cone-beam computed tomography 
(CBCT) was used in the patient setup. The isocenter shifts between the CBCT and linac were 25 
measured for a Varian Trilogy linear accelerator for three months. For each plan, we shifted the 
isocenter of the plan in each direction by ±3 mm simultaneously to simulate the worst setup 
scenario. Subsequently, the asymptotic behavior of the CTV V80% for each patient was studied as 
the setup error approached the CTV-PTV margin.  
Results: We found that the proper margin for single-fraction frameless SRS cases with brain 30 
cancer was about 3 mm for the machine investigated in this study. The isocenter shifts between 
the CBCT and the linac remained almost constant over a period of three months for this specific 
machine. This confirmed our assumption that the machine systematic error distribution could be 
approximated as a delta function. This definition is especially relevant to a single-fraction 
treatment. The prescribed dose coverage for all the patients investigated was 96.1±5.5% with an 35 
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extreme 3-mm setup error in all three directions simultaneously. It was found that the effect of 
the setup error on dose coverage was tumor location dependent. It mostly affected the tumors 
located in the posterior part of the brain, resulting in a minimum coverage of approximately72%. 
This was entirely due to the unique geometry of the posterior head.  
Conclusions: Margin expansion formulas were derived for single-fraction frameless SRS such 40 
that the CTV would receive the prescribed dose in 95% of the patients treated for brain cancer. 
The margins defined in this study are machine-specific and account for nonzero mean systematic 
error. The margin for single-fraction SRS for a group of machines was also derived in this paper. 
 
Keywords: margin, cone-beam computed tomography, image-guided radiotherapy, stereotactic 45 
radiosurgery, brain cancer 
 
 
I. INTRODUCTION 
Stereotactic radiosurgery (SRS) has gained increasing popularity as a treatment modality for 50 
patients with brain metastases.
1
 SRS has traditionally been performed by using an invasive fixed 
head frame that establishes the stereotactic coordinates of the target.
2
 More recently, frameless 
stereotactic systems have been developed and implemented with the help of an image-guided 
system.
3-10
 
 In a previous paper,
11
 a three-dimensional (3D) margin expansion formula was proposed 55 
to derive the planning target volume (PTV) from the clinical target volume (CTV) for SRS. In 
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that derivation, it was assumed that the setup errors in all directions were the same. This may not 
be clinically realistic in most cases. However, the previous formula is valid if the maximum 
margin is used in all directions. This approach, nevertheless, will inevitably result in over dosing 
more healthy brain tissues. In this paper, we will derive the mathematical formulas for three one-60 
dimensional (1D) expansions of the CTV–PTV margin in an effort to minimize the unnecessary 
dose to the organs at risk (OARs) and, in the meantime, to provide a minimally required margin 
for an effective and safe single-fraction treatment. A1D expansion means that the uni-
dimensional margin is derived individually and applied to its corresponding principal axis of a 
3D coordinate system. The differences between 1D and 3D expansions are graphically 65 
demonstrated in Fig.1. We would like to explicitly state here that the fundamental objective of 
this study is to derive a mathematical formula to quantitatively determine the treatment margin to 
account for patient setup uncertainty. The detailed computational algorithm on volume expansion 
is not the central point of this paper. 
 Reports on the CTV–PTV margins for frameless SRS using cone-beam computed 70 
tomography (CBCT) are rare. The main reason for this may be that the setup accuracy has been 
extensively studied and explored for image-guided radiation therapy (IGRT).
12 
Thus, many 
people may no longer consider the CTV-PTV margin as a major clinical issue. However, the 
effects of the systematic isocenter shifts between the CBCT and the linac’s radiation beam have 
not been systematically investigated. This isocenter discrepancy directly affects the exact 75 
definition of the CTV-PTV margin. This is especially true for SRS cases where the margin is 
normally in the order of millimeters. For multi-fraction treatment regimens, various 
mathematical models for margin determination have been proposed, investigated, and 
implemented.
13-24 
However, those formulas generally vary from publication to publication.
13
 For 
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example, the CTV–PTV margin recommended by the ICRU (International Commission on 80 
Radiation Units and Measurements)Report 62
14
 is different from van Herk’s formula.19 A 
detailed discussion on the definitions of the CTV and the PTV can be found in relevant ICRU 
Reports
15 
and also in a seminar article.
16 
Owing to this, readers are kindly reminded that the 
determination of the CTV–PTV margin is not an exact science at this point.16 Because the current 
margin design still adopts an empirical approach, the physicians’ clinical experience plays a 85 
crucial role in the margin determination.16 There are many contradictions and inconsistencies 
among margins for frameless SRS. These are due to several reasons. One of them is that 
frameless SRS is a new treatment modality compared to traditional frame-based SRS. 
Consequently, radiation oncologists tend to apply their previous clinical practice directly to 
frameless SRS margin design without any modification. Our recent informal survey shows that 90 
the margin for linac-based frameless SRS varies significantly, from zero to several millimeters 
for a dozen of academic institutions. Contrast-enhanced computed tomography (CT) and 
magnetic resonance imaging (MRI) can help radiation oncologists accurately delineate the tumor 
volume. Previous studies have found that a 1-mm margin is needed for expansion from the gross 
tumor volume (GTV) to the CTV.
25-26 
However, the technologies used in those studies are 95 
different from the one employed in this investigation. In this paper, similar to the approaches 
adopted by previous multi-fraction margin publications, we will ignore the delineation 
uncertainties and concentrate on an important, but unsolved physics problem, the effects of the 
systematic error between the CBCT and the linac isocenters on the margin determination.  
 Mathematically, it is not a trivial task to determine a clinically meaningful margin with 100 
many uncertainties. ICRU Report 50
15
 does not recommend adding all uncertainties linearly 
because this would produce a much larger margin than the clinically needed. Therefore, different 
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margin formulas have been proposed based on different assumptions. However, all those 
previous studies, both theoretical and clinical ones, have been confined to multi-fraction 
treatments only. The formulas thus derived cannot be directly applied to single-fraction SRS. In 105 
addition, because the isocenter shifts between the CBCT and the linac overlap with the setup 
error, one had better not simply combine the two linearly. Otherwise, the margin so constructed 
would be overestimated. In this paper, we will provide an alternative but novel method for 
margin determination, specifically for single-fraction SRS. In contrast to previously published 
approaches, our margin formulas explicitly include the isocenter shifts as one of the systematic 110 
errors in our derivation. 
We assume that frameless SRS is performed on a linac with CBCT capability. On such a 
premise, two coordinate systems can be established: one with the origin placed at the CBCT 
isocenter and the other one with the origin placed at the linac isocenter. By default, the two 
coordinate systems use the same mathematical convention so that their corresponding axes are 115 
about parallel to each other. For IGRT-based SRS (IG-SRS), the planning CT isocenter is 
implicitly assumed to be at the linac isocenter. Thus, upon a successful completion of the image 
registration between the CBCT and the planning CT, the CBCT isocenter should, in theory, 
coincide with the planning CT isocenter, i.e., the linac isocenter. However, due to linac 
mechanical limitations, CBCT isocenter shift, CT image quality degradation, and human factors, 120 
there are a number of uncertainties constantly present in the patient setup. Those uncertainties 
can be broadly classified into two types: (1) systematic errors, including, for example, image 
registration error, target delineation uncertainty, and inaccurate isocenter position; and (2) 
residual setup errors, including inaccurate 4-degrees-of-freedom (DOF) couch positioning (three 
translations and one rotation) caused by a finite couch stepping precision, leading to not only 125 
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non-negligible residual setup errors, but also a preclusion of a full 6-DOF error correction (three 
translations and three rotations) and errors induced by an incorrect order of rotation and 
translation operations. 
 This paper is presented as follows: Section II (Methods) describes the mathematical 
relation between the probabilities that patients receive the prescribed dose and derives the 130 
margins for three independent1D expansions. In addition, Section II also derives the margin 
formulas for a group of machines and the entire patient population. Furthermore, Section II 
provides the margin formulas for 3D expansion such that the CTV receives the prescribed dose 
in 95% of the treated patients. Section III (Results and Discussion) elaborates on the differences 
between our margin formulas and previously published ones and describes a procedure for 135 
measuring the isocenter shifts between the CBCT and the linac. In addition, Section III also 
presents our data on the CTV coverage for nine patients when the setup error approached the 
CTV-PTV margin simultaneously in all three directions. Section IV provides our conclusions. 
 
II. METHODS 140 
II.A. General approach 
 Adopting the convention widely used by previous investigators,
22-23 
we make following 
assumptions on SRS to facilitate our margin formula derivations: (a) Variation in beam profiles 
within the PTV is negligible; (b) CT numbers do not change dramatically in this region; and (c) 
the surface curvature does not vary appreciably. Currently, our institution employs a 3D static 145 
conformal technique for single-fraction frameless SRS. The treatment dose is prescribed to the 
80% isodose surface that, ideally, should cover the entire CTV, i.e., V80% = 100%. 
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 For each patient, the percent CTV covered by the prescribed dose ( DcV ) can be calculated 
by the following equation:
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where cD  is the prescribed dose, i.e., the 80% isodose surface, throughout this paper.
11
 Here, the 
integration is performed over the points inside the CTV and )(xH  is a step function that equals 1 
when x>0 and zero otherwise.  ),( cD DVV c

, representing an integral volume, is a function of cD  
and the CTV isocenter shift vector V

. CBCTD  
is the dose in the patient CBCT scan and CTD  
is the 
dose in the planning CT. The probability that the CTV receives cD  
can be expressed as
11
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where )(xH  is the aforementioned step function and cV  
is a threshold value of DcV , set as 100% 
in this paper. )(VP

 is the probability distribution of the isocenter shift vector rs VVV

  for all 
patients and can be expressed as: 
          rsrsrs VdVdVVPVVVVP

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Here, ) , ( rs VVP

 
is the probability distribution for the systematic error ( sV

) and residual setup 
error (
rV

). 
 To complete Eq. (2), we need two functions )(xDCT  
and )(VP

. Function )(xDCT  
represents the dose that covers the CTV in the planning CT. For a 3D conformal treatment plan, 
the CTV coverage is its objective function, i.e., mathematically, cCT DxD )( . The exact form of 165 
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the dose distribution function within the PTV is actually not so critical for a 3D conformal plan. 
Therefore, the CTV–PTV margin is determined mainly by the distribution function )(VP

 in Eq. 
(2).  
 In a previous publication,
11 
the standard deviations of the residual setup errors were 
assumed to be equal in all three directions (x, y, and z). In this section, we will provide a solution 170 
to cases that have significantly different standard deviations in these directions.  Under such a 
circumstance, one can expand the tumor volume anisotropically, i.e., moving the PTV surface 
along a direction for a certain distance. Such an approach would be easily understood graphically 
if the tumor shape resembled a box. Given this assumption, ), ( rs VVP

 
can now be explicitly 
written as follows: 175 
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where rxV , ryV , and rzV  are the three components of the residual setup errors in x, y, and z 
directions, respectively; 0sV

 
is the systematic error, which is a constant for a specific machine; 
xrV 0 , yrV 0 , and zrV 0  
are the three components of the mean residual setup error ( 0rV

). Here, 0sV

 
represents the isocenter shifts between the CBCT and the linac. ),,( zyxii   is the standard 180 
deviation of the setup error in the thi  
direction. The residual setup errors are included in the 
following cases: (1) residual setup errors with a shift correction <1 mm in each direction post-
registration; (2) original setup errors that are so small that shift corrections are not needed.  
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II.B. One-dimensional expansion margins for a single-fraction SRS case and a 185 
specific machine 
 In this section, we will construct a model to obtain the relationship between the 
probability of successful treatment and the margin required for a single-fraction SRS case. In this 
derivation, the systematic error is assumed to be the isocenter shifts between the CBCT and the 
linac. The derivation can be generalized to include all those systematic errors that are constants 190 
during treatment. 
 Assuming unequal margins and symmetrical volume expansion in each direction, Eq. (2) 
can be rewritten as:  
  .),()  ()  ()  ( srrszzyyxx VdVdVVPVCHVCHVCHP

           (5) 
where 
zyx CCC  and , ,  
are the margins in the zyx ,,  directions, respectively, and zyx VVV  and , ,  
195 
are the three components of the isocenter shift vector rs VVV

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

 
and 
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Eq. (6) can be rewritten as 
zyx PPPP     
if we define the components  zyxiPi ,,  as follows 
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where  
x
dttxerf
0
2  )exp(
2
)(
  
is the error function. 
 
II.C. One-dimensional asymmetrical expansion  
 Supposing that a treatment planning system has a function to allow asymmetrical 
boundary expansion in each direction, one can define the following margin, with left-right (LR) 205 
as the x direction, anterior-posterior (AP) as the y direction, and feet-head (FH) as the z direction: 
  
.  ) ,( )()(
)()()()(
rsrszHzF
yPyAxRxL
VdVdVVPVCHVCH
VCHVCHVCHVCHP


 
          (8) 
where ) and ,,,,,( HFPARLiCi   
is the margin in each direction. It is easy to see that the 
asymmetric margins can be converted to symmetric margins by defining xxL WCC 0 , 
xxR WCC 0 , yyA WCC 0 , yyP WCC 0 , zzF WCC 0 , and zzH WCC 0 . Thus Eq. 210 
(8) becomes: 
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II.D. One-dimensional expansions for all machines and patients  215 
 As a comparison, we will also calculate the margins for a group of machines on which all 
patients are treated with single-fraction SRS. In this scenario, the systematic errors are different 
12 
 
for different machines and we assume that they follow a Gaussian function, as in a majority of 
publications. We will determine the margins for three 1D expansions. 
 When the residual setup errors or systematic errors change dramatically in each direction, 220 
one needs to expand the representative tumor volume independently in each direction. In this 
case, ) ,( rs VVP

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where ) and ,,( zyxii   
is the standard deviation of the isocenter shifts within a group of linacs. 225 
By bringing Eq. (11) into Eq. (2), we yield iP  (i = x, y, and z) and zyx PPPP    , 
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Where 
irisi VVW 000  . At this point, we have derived the relations between the margins and the 
probabilities that the CTV receives the prescribed dose for three 1D expansions. 
 230 
II.E. Margin for symmetric 1D expansion 
The following procedures are used in the derivation of the margin formula for three 1D 
expansions: (1) For a 1D expansion, Eq. (7) is used to obtain the relation between iC  and i  for 
13 
 
a fixed iW0  
and 98.0iP . Polynomial functions are used to fit those relations and the 
corresponding coefficients are then obtained. (2) Repeating the above process for a different iW0 , 235 
the coefficients as a function of 0W  
are obtained.  Thus, the margin formula for a specific 
machine was finally obtained. For a group of machines, due to the similarity between Eq. (12) 
and Eq. (7), the derivation procedure in this case is very similar to that for a specific machine. 
 If 95.0P , 98.0)95.0(
3/1  zyx PPP . We will expand the margin Ci (i=x, y, and 
z)
 
for each direction as:  240 
   .  )( )( 202010 iiiiii WbWbWC             (13) 
We will first calculate iC  vs. i  for each different iW0 , then we will use Eq. (13) to fit the curve 
to get )( 01 iWb  
and )( 02 iWb . After that, we will fit )( 01 iWb  
and )( 02 iWb  as a function of iW0 . 
With this numerical approach, we have found that the behavior of the margin parameters could 
be fitted in functions as depicted in Fig. 2 and Fig. 3: 245 
  4
0
3
0
2
0001  374.0 539.1 296.2 425.1331.2)( iiiii WWWWWb  ,       (14) 
and 
  .  171.0 676.0 917.0 434.0)( 40
3
0
2
0002 iiiii WWWWWb          (15) 
Here, we need to point out that in the limit of 00 iW , we obtain b1(0) = 2.331 and .02 b  
Therefore, the margin formula (Eq. 13) is reduced to:  250 
    331.2IIC .          (13a) 
Eq. (13) is an approximated solution to Eq. (7).  To confirm its accuracy, we have solved Eq. (7) 
numerically for wide ranges of σ and W0i, from 0.0 to 1.5 mm in a step size of 0.15 mm for W0i 
14 
 
and from 0.05 to 2.5 mm in a step size of 0.05 mm for σ. We have found that the greatest 
difference is only 0.013 mm. Therefore, we can conclude with full confidence that the formula 255 
provided in this paper can be legitimately applied to single fraction cases if the standard 
deviation of the residual setup error is ≤ 2.5 mm and the isocenter shift is ≤ 1.5 mm. As a 
concrete evidence, we hereby provide a plot for a typical clinical case when W0i = 0.8 mm. The 
exact and approximated solutions given by Eq. (7) and Eq. (13), respectively, are plotted in Fig. 
4.  260 
 
II.F. Margin for Asymmetric 1D expansion  
 For 1D asymmetric expansion, we have 
   iiC  331.2 ,                        (16) 
with  i = x, y, and z and the corresponding margins being xxL WCC 0 ; xxR WCC 0 ; 265 
yyA WCC 0 ; yyP WCC 0 ; zzF WCC 0 ; and zzH WCC 0 . 
 Graphically, the margin so defined is equivalent to copying the CTV to a new position 
) , ,( 000 zyx WWW  and then expanding it with a margin iC . If we assume 0i , then we have a 
“copy CTV”. Delivering treatment using this copied CTV has significant shortcomings: the 
relative position of this copied CTV with respect to the original patient position is not the same. 270 
Consequently, the delivered dose distribution in the CBCT CTV will deviate from the planned 
dose distribution in the original plan CTV, as demonstrated in Fig. 5. The image on the left in 
Fig. 5 is the planning CT with the original CTV. To achieve the treatment planning objective, the 
planning beam arrangement should cover the entire CTV adequately. Assuming that the CTV is 
copied to or reproduced in a different location in space (the image on the right in Fig. 5) because 275 
15 
 
of the isocenter shift between the CBCT and the linac, the beams would have moved by the same 
amount accordingly. Therefore, during the real treatment, this isocenter discrepancy would 
inevitably lead to a deviated patient’s dose distribution from that calculated. In theory, one could 
use two sets of CT scans for daily clinical cases: one for planning (the left one) and the other one 
for positioning (the right one). However, the current technology does not support this dual CT 280 
scan function and, in addition, this method is also impractical for a busy clinical center from a 
logistical point of view. This shortcoming might not be significant if i  were very large. 
However, one should be cautious when using asymmetric expansion and should also realize that 
there are some uncertainties in dose calculation as well.  
 285 
II.G. Margins for all patients and all machines 
 The derivation of margins for all patients and all machines is quite similar to that for a 
specific machine. For a group of machines and the whole patient population, the margin for 
single-fraction SRS is   
   .  )()( 220222010 iiiiiiigroupi WbWbWC           (17) 290 
where i = x, y, and z. )( 01 iWb  
and )( 02 iWb  
have the same function format as in Eq. (14) and Eq. 
(15). Here, i  
is the standard deviation of the isocenter shifts, but it can be extended to include 
any systematic error. As a comparison, van Herk’s formula for the 1D expansion (for 98% 
confidence and 98% minimal dose to the CTV) is going to be 
    06.2331.2 vanHerkC .          (18) 295 
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 where   is the standard deviation of the systematic error for a group of machines and   is that 
of the setup error for a patient population. Here, we need to point out that van Herk et al. did not 
study the impact of the isocenter shifts on margin determination in their paper. We will take   as 
the isocenter shifts’ i  in Eq. (17). The difference between Eq. (17) and Eq. (18) is shown in 
Fig. 6. In the plot, we take mm 6.00 iW . On the one hand, it is apparent that when the residual 300 
setup error is very small, our margin is greater than van Herk's. This is due to the fact the mean 
of the residual setup error is not zero in reality and it was ignored in van Herk's derivation. On 
the other hand, when the residual setup error is very large, van Herk's margin is greater than 
ours. This results from the methodology used in van Herk’s derivation. His margin formula is for 
multi-fraction treatment regimens only. Thus, it is not difficult to explain the phenomenon shown 305 
in Fig. 6. 
 The margin formulas developed in Section II. E. have been implemented clinically. The 
complete procedure involved three steps: (1) measuring the isocenter shift for the linac used; (2) 
calculating the required margin for the patient; and (3) determining the effect of setup errors on 
the CTV dose distribution.  310 
 
II.H. The procedure to determine frameless SRS margins for a specific machine 
 Currently, the frameless SRS at our institution is performed with an AKTINA PinPoint 
Radiosurgery System (AKTINA Medical, Congers, NY). The treatment is delivered on a Trilogy 
linac (Varian Medical Systems, Palo Alto, CA). The CBCT acquisition protocol is the Varian 315 
pre-set CBCT “Pelvis” mode. We have chosen the “Pelvis” mode over the “High Quality Head” 
mode because the “Pelvis” mode usually produces images with better quality.9-10 An AlignRT3D 
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optical surface imaging system (Vision RT, UK) is routinely used for both patient pre-setup and 
residual setup error measurement. The residual setup errors are defined as the differences 
between the observed AlignRT values before and after CBCT registrations. 320 
 
II.H.1. Measurement of isocenter shifts for a specific machine 
 For the specific Trilogy machine used, we measured the isocenter shifts between the 
CBCT and the linac on a weekly basis for three consecutive months. A metal sphere with a 6-
mm diameter was positioned near the radiation isocenter using the linac crosshair as guidance. In 325 
the first part of the test, a series of Winston-Lutz tests were performed using a 2 × 2 cm
2
 field at 
the gantry angles of 0°, 90°, 180°, and 270°. The radiation fields were defined by a multi-leaf 
collimator. The radiation isocenter was assumed to be the intersection point of the central axes of 
each field. We took the average apparent positions of the sphere to compute an average radiation 
isocenter position. Knowing the average radiation isocenter position, we imaged the sphere using 330 
CBCT at the highest resolution with a slice spacing of 1 mm, a matrix size of 512 × 512, and a 
field-of-view (FOV) of 26 cm.  The difference between the two isocenter positions reported by 
the imaging system and computed with the Winston-Lutz tests was defined as the systematic 
error. The Winston-Lutz test is one of the standard QA procedures performed at our institution.
27 
It was found that all isocenter shifts fluctuated within a very narrow range and were different for 335 
different machines, but all were less than 1 mm. Fig. 7 shows the isocenter shifts as a function of 
time. Similar observations have also been reported in the literature.
28
 
 
II.H.2. Margin determination for a specific machine 
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 In the derivation above, we only considered the isocenter shifts for a normal couch 340 
position (0°). However, for a realistic SRS treatment, non-coplanar beams are often employed in 
an effort to achieve a high degree of isodose conformality. Thus, possible couch shifts also exist. 
Under this circumstance, the systematic error 0sV

 
is a function of couch angles. To simplify the 
derivation, one can use the maximum components of    V

 
in our calculation. Here, 
shiftcouchshiftisos VVV __0

 , containing both isocenter shifts and couch shifts. In our clinical 345 
investigations, we have found that the maximum isocenter shift was approximately 0.5 mm in 
each direction and the maximum couch shift was also approximately 0.5 mm. Our method was 
similar to the one given in Ref. [6]. However, our measurement results were somewhat different 
from theirs. For the frameless SRS cases that we have studied, the collimator angle was fixed. 
Therefore, we have assumed 1 mm as its systematic error, the worst case scenario in our study.  350 
 Because of the technical limitations of current verification systems, it is difficult to 
estimate the CBCT-induced residual setup error without a significant amount of extra effort. We, 
instead, have used surface imaging for this purpose. The validity of this approach is based on our 
clinical observations. We have found that a carefully calibrated surface imaging system can 
provide not only more accurate translational shifts (in the order of 0.1 mm) than CBCT, but also 355 
consistent and reproducible results. The surface imaging system has three significant advantages 
over CBCT. It uses light as the imaging source, employs more than 30,000 points for image 
registration, and is real-time in image reconstruction and registration. Thus, it can be repeatedly 
applied to the patient, making the residual setup error assessment safe, accurate, and efficient. In 
this study, the patient's shifts detected by surface imaging measurement after the final CBCT 360 
scan is considered as the residual setup error of the image-guiding system. 
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 The residual setup errors were measured for 30 patients treated at one of our Regional 
Centers. The results and the required corresponding margins are listed in Table I. As expected, 
the mean of the residual setup errors was not zero. The maximum mean was about 0.2 mm, 
leading to a maximum value of W0i = 1.2 
mm. Substituting this iW0  
and i  into Eq. (13) yielded 365 
the margin in each direction. For the sake of simplicity, we did not use unequal margins for 
different directions, a practice similar to the conventional frame-based SRS procedure.
2 
Nevertheless, we can use unequal margins in the future if clinically necessary. In the following 
section, a maximum margin of iC  
 3 mm is used in our demonstration. 
 370 
III. RESULTS AND DISCUSSION 
 As we mentioned in Section II, several assumptions have been made in our margin 
formula derivations. Although we argued that these assumptions had been widely used by other 
investigators in their margin studies, we have nevertheless validated these assumptions by 
calculating the dose distribution for a previously treated patient. The dose calculation platform 375 
used is BrainLab iPlan (BrainLab AG, Germany). The CTV dose coverage was calculated as a 
function of the isocenter shifts between the CBCT and the planning CT.  The cube in Fig. 8 
shows the CTV %80V  
for a hypothetical situation with a 3-mm setup error in all three directions 
simultaneously. It represents the worst clinical scenario that occurs with a very small probability 
in reality. It was intended for demonstration only. In each direction, the probability of the setup 380 
error ≥ 3 mm is: 1-0.98=0.02. With a simple calculation, one can find that the probability for 
cases in which the setup errors are more than 3 mm in all directions simultaneously is less than 8 
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× 10
-6
. For the eight points on the corners of the cube in Fig. 8, it was found that %80V  
was higher 
than 95%. Thus, we can conclude that as long as the setup errors fall within this cube, %80V  
 
95%. 385 
 There are many possible causes for the results shown in Fig. 8. For example, the 
imperfect volume expansion from the CTV to the PTV by the treatment planning system may 
cause a small fraction of voxels to receive a dose less than the prescribed one even if the setup 
error is less than 3 mm in each direction. In addition, the uncertainties in the dose calculation 
algorithm can also lead to an appreciable dosimetric error for certain types of tissue. We will not 390 
discuss those factors in this paper since they are beyond the scope of our present study. 
 In our derivation, we assumed that as long as the isocenter shifts were within the 
calculated margin (3 mm with a probability of occurrence = 95%), the CTV would receive the 
prescribed dose. Thus, the results shown in Fig. 8 may reveal that these assumptions are, 
perhaps, not realistic and perfect. From a theoretical point of view, it would be valuable to be 395 
able to validate those assumptions based on a group of patients. To this end, we have performed 
the same analysis for nine previously treated IG-SRS patients with a total of 11 PTVs (two 
patients had two tumors each). Fig. 9 shows the probability distribution of %80V  (3-mm shifts 
from the isocenter in all three directions at the same time) for this group of patients. As clearly 
demonstrated, the majority of the points (71 out of 88) fell in the range of %80V  ≥ 95% with a 400 
probability ≥ 80%. Nevertheless, a few points (2 out of 88) did exhibit undesirable CTV 
coverage ( %80V ≤ 80%). This occurred with a probability ≤ 3% according to Fig. 8. This tells us 
that the assumptions have failed for these points. In fact, mathematically, the probability for each 
point to have a 3-mm shift in all three directions simultaneously is less than 8 × 10
-6
. In Fig. 10, 
21 
 
the average values for %80V  for those 11 PTVs (the average of eight points for each PTV) are 405 
given. Though almost all the average values were larger than 95%, one outlier did fall 
somewhere between 70% and 80%. Further investigation has revealed that the CTV of this case 
was located at the far posterior side of the brain, where the surface curvature changed very 
rapidly, thus violating our third assumption. We should emphasize again that the probability for 
each point to have a 3-mm shift in all directions simultaneously is extremely small. For this or 410 
similar type of cases, a larger margin is required to compensate for this effect. To further 
investigate the phenomenon unveiled in Fig. 10, we have also calculated the additional margins 
needed for each of the 11 PTVs. For each tumor, we expanded the CTV-PTV margin such that 
our dosimetric objective of %80V  
 99.9% could be easily achieved even if the isocenters were 
displaced by 3 mm in all three directions simultaneously. The difference between this new 415 
margin and the 3-mm margin was specifically called the additional margin in this paper. For the 
11 tumors, there were a total of 88 cases that had 3-mm isocenter shifts in all three directions 
simultaneously, giving 88 additional margins. The frequency distribution of these additional 
margins is shown in Fig. 11.  A Gaussian function was used to fit the additional margin 
distribution. It was found that the average additional margin needed to achieve our goal was 0.65 420 
mm, with a standard deviation of 0.3 mm. The largest margin corresponded to the case where the 
tumor was in the far posterior side of the brain. This approach provided a practical solution to 
clinical implementation. To obtain the necessary margins for each specific CTV, one can first 
use the method demonstrated in Fig. 8 to estimate the projected %80V  
for the corresponding 
margins. With additional margins, one would be able to achieve %80V  
 99.9%.  In this study, the 425 
statistical analysis toolbox ANOVA1 in MATLAB (The MathWorks, Inc., MA) was used to test 
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the statistical significance of the difference between %80V  
before and after the addition of this 
extra margin. The difference with p < 0.05 was considered statistically significant. It was found 
that the addition of extra margins increased the CTV %80V  significantly with p < 0.01. However, 
as previously stated, the setup error of ±3 mm occurring simultaneously in all directions is a very 430 
small probability event under normal clinical conditions. Therefore, for practical purpose, we can 
simply ignore this extra 0.65-mm margin. 
 In this paper, we have quantitatively explored the effects of the isocenter shifts between 
the CBCT and the linac on the margin determination. Because of the potential overlap between 
the isocenter shifts and setup error and the isocenter shifts being constant over a long period of 435 
time, our margin formulas differ from the previous ones, which assumed a Gaussian function for 
the systematic errors. In our derivation, certain types of the systematic errors were not considered 
in our mathematical models. These included the target delineation error and the image 
registration errors. The target delineation error was intentionally excluded in the present study 
because of the scarcity of clinical data. However, if we assumed that the target delineation error 440 
was a Gaussian function, then we could include it in our margin formulas by changing the 
standard deviation σ to a square root of the sum of the variance of the setup error and the 
variance of the target delineation error and bring it into our formulas in this paper. Similarly, we 
could also include the image registration error in our modeling. The validity of this approach, of 
course, depends on the specific function format of each systematic error, which, in our opinion, 445 
should be studied extensively. However, as long as the function format is known, the procedure 
presented in this paper can be used to drive a new margin formula. 
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 Previous publications on margin formulas concentrated on a group of patients and a 
group of machines only. van Herk’s formula is one of those and has been widely cited in 
publications. In van Herk’s derivation, it was assumed that the contributions from the setup error 450 
and the systematic error were different. Our margin formula aims at a single-fraction IG-SRS 
and a specific machine. In our derivation, it was assumed that the contribution from the setup 
error and the systematic error were the same. Therefore, it is not surprising that there are 
differences between our formulas and van Herk’s. In a previous publication, it was assumed that 
the nonzero constant systematic error could be corrected by couch shifting. However, this 455 
technique is not effective for the sub-millimeter systematic errors (or residual systematic error) 
because current 4-DOF couches are not equipped with high-precision stepping motors. 
Nevertheless, this systematic error is explicitly included in our margin formulas. On the other 
hand, this non-zero constant systematic error is ignored in the previous derivations.
2111
 
 People are cautioned if they intend to apply our margin formulas to their IG-SRS 460 
programs and machines. They must determine their specific systematic error and verify its 
function format. For example, for the CBCT setup technique, they would need to determine their 
own isocenter shifts and make sure that these shifts are almost constant. Subsequently, they can 
substitute their isocenter shifts into the formulas given in this paper. For multiple systematic 
errors, the best way to include them in the margin formulas is to determine the function format of 465 
the combined systematic error. If the combined systematic error is a constant, then it can be used 
to replace the isocenter shifts in the formulas in this paper. 
 As the treatment margin is a statistical quantity, it is, therefore, aimed at benefiting the 
majority of the patient population, rather than a specific one. In this study, it is assumed that the 
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setup errors follow a Gaussian distribution. The margin formula is derived such that it will cover 470 
setup errors in up to 95% of all SRS patients. Consequently, by definition, those 95% patients 
will be over-compensated or overdosed. In fact, only those patients whose setup errors are 
exactly the same as the expansion margin will not be overcompensated, nor will these tumors be 
missed. Overcompensation is an intrinsic phenomenon or deficiency in margin formulas 
Therefore, we strongly urge our readers and colleagues to carefully examine their patients’ setup 475 
errors in order to arrive at their own specific expansion margins.  However, for multi-
fractionated treatment protocols, there is indeed one practical approach to avoid or alleviate 
margin overcompensation. That is the patient specific margin. In this context, one could derive a 
margin based on n treated fractions for that particular patient and then use this derived value for 
adaptive treatment planning.
29
 Nevertheless, this method is not applicable to single fractionated 480 
treatment. 
 
IV. CONCLUSIONS  
 The margin definition described in this paper is machine-specific and more appropriate 
for single-fraction IG-SRS. Two different types of volume expansion strategies have been 485 
presented in the paper: (1) asymmetric expansion and (2) symmetric expansion that includes the 
nonzero constant systematic error. Margin formulas for single-fraction frameless IG-SRS and a 
group of machines have also been derived. It has been found that this nonzero constant machine 
systematic error made the margin formulas more complex than the previous ones. Our margin 
formulas are innovative and have never been reported previously. Our methodology eliminates 490 
the assumption used in the previous margin formula derivations, i.e., the mean systematic error 
25 
 
(or mean residual systematic error) is zero, thereby, making it more general and practical for 
clinical applications. 
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Table I. The residual setup errors measured with an AlignRT system for patients treated at one of 
our Regional Centers and their corresponding margins calculated with our method. Unit: mm 
Residual setup error LR (left-Right) SI (superior-inferior) AP (anterior-posterior) 
Mean -0.17 0.10 -0.03 
Stand Deviation σ 0.59 0.81 0.43 
Margin 2.41 2.87 2.08 
580 
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Figure Legends 
Figure 1 
Examples of 3D symmetric expansion, 1D symmetric expansion, and 1D asymmetric expansion. 
The 3D expansion is a symmetric expansion of the base volume by the same distance in all 585 
directions (left), whereas 1D expansion can be symmetric (middle) or asymmetric (right). The 
inner circle is the CTV, and the outside contour is the PTV. For demonstration purposes, only 2D 
images are shown. 
 
Figure 2 590 
Behavior of the margin parameter )( 01 iWb as a function of iW0 . 
 
Figure 3 
Behavior of the margin parameter )( 02 iWb as a function of iW0 . 
 595 
Figure 4 
The exact and approximated solutions computed by Eq. (7) (circle) and Eq. (13) (solid line), 
respectively. The differences between those two solutions are indicated by the dotted line. 
 
Figure 5 600 
A demonstration of the possible dose error occurrence when using the “CTV copy” technique.  
The left image is the planning CT with the original CTV. The beam arrangement should cover 
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the whole CTV. The CTV is moved to a new location because of the isocenter shift between the 
CBCT and the linac (right). A and B indicate the beam edges. 
 605 
Figure 6 
The differences between van Herk’s formula and our formula for a group machine and a group 
patient as a function of  . But different methodology has been used in the derivation of van 
Herk (Eq. (18)) and ours (Eq. (17)). 
 610 
Figure 7 
The measured isocenter shifts between the CBCT and the linac as a function of time. Isocenter 
shifts remain approximately constant over a three-month period. 
 
Figure 8 615 
The V80% values when the linac and CBCT isocenters differ by 3 mm in all three directions 
simultaneously. The center of the cube represents the linac isocenter. Each point on the corner 
represents the worst clinical scenario that barely occurs in reality (with a probability less than 8 × 
10
-6
). 
 620 
Figure 9 
Frequency of the CTV V80% of 11 clinical tumors for the extreme case when there were 3-mm 
shifts in all directions simultaneously. A total of 88 points were obtained for these 11 clinical 
tumors. 
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 625 
Figure 10 
The average CTV V80% for each of the 11 tumors in nine patients when the setup errors were 3 
mm in all three directions simultaneously. Each point represents the worst clinical scenario. 
 
Figure 11 630 
The frequency distribution of the additional margins.  A Gaussian function was used to fit the 
distribution. 
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